In 2023, the mortality rate from neoplasms in Brazil was 182.4 deaths per hundred thousand persons. From 2024 to 2028, the rate is forecasted to increase slightly year-on-year: 182.8 in 2024, up to 184.4 by 2028. This reflects a steady rise in neoplasm mortality, with an average annual growth rate (CAGR) of approximately 0.22% over these years. Over the last two years, the rate's growth reflects a continuous and gradual upward trend, highlighting a concern for public health.
Looking ahead, factors such as advancements in medical technology, early detection programs, and policy measures to reduce risk factors will significantly influence mortality trends. Monitoring these elements will be crucial in forecasting future changes and implementing effective interventions.
